Jan 29, 2016 - Mario Gabelli Comments on TNT Express NV, Stocks: TNTE, Mario Gabelli, release date:Jan 29, 2016
Dec 22, 2015 - Gilead Sciences announced they have taken an equity stake in Galapagos NV.The move is an interesting one, Galapagos lead product is outside the field of oncology.The article below will examine the dea
Oct 23, 2015 - LyondellBasell Industries NV (NYSE:LYB)Q3 2015 Earnings CallOctober 23, 2015 11:00 am ETExecutivesDouglas J. Pike - Vice President, Investor RelationsBhavesh V. Patel - Chief Executive Officer & Chair
Sep 17, 2015 - Mylan NV (NASDAQ:MYL) Morgan Stanley Healthcare Conference Call September 17, 2015 2:40 PM ET Executives Heather Bresch - Chief Executive Officer John Sheehan - CFO, EVP, Principal Financial & Acc
Sep 14, 2015 - Merck KGaA (MKGAF) announced that it has submitted a letter of intent to the EMA to file a marketing authorization application for MS candidate, cladribine.
Sep 14, 2015 - Mylan NV continues aggressive bid for fellow generic drug maker Perrigo with a tender offer to shareholders.
Sep 11, 2015 - Aduro (ADRO) signed a clinical study agreement with Incyte (INCY) to evaluate CRS-207, in combination with Incyte's epacadostat, in patients with ovarian cancer.
Sep 07, 2015 - Novartis' (NVS) Farydak (plus Velcade and dexamethasone) gets EU approval for relapsed and/or refractory multiple myeloma in treatment-experienced patients.
Sep 03, 2015 - Novartis (NVS) launched Zarxio (biosimilar version of Amgen's Neupogen) in the U.S., which became the first FDA-approved biosimilar to be launched in the country.
Sep 02, 2015 - Amgen (AMGN) inks deal with Novartis for Alzheimer's disease and migraine; reports positive phase III data on romosozumab.